Page last updated: 2024-08-24

sulofenur and Neoplasms

sulofenur has been researched along with Neoplasms in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19902 (22.22)18.7374
1990's7 (77.78)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Avery, L; Bowman, LC; Luo, X; Marina, N; Meyer, WH; Pappo, A; Pratt, CB1
Brown, TD; Burris, HA; Cagnola, J; Craig, JB; Grindey, GB; Hamilton, JM; Havlin, K; Kuhn, JG; O'Rourke, TJ; Satterlee, WG1
Andersen, E; Andersen, H; Hansen, HH; Krarup-Hansen, A; Pedersen, H1
Brown, TD; Burris, HA; Havlin, KA; O'Rourke, TJ; Rodriguez, GI; Wall, JG; Weiss, GR1
Diasio, RB; Stagg, MP1
Hamada, K; Inoue, K; Mukaiyama, T; Ogawa, M; Shibata, H; Wang, Y1
Grindey, G; Hainsworth, JD; Hamilton, M; Hande, KR; Jackson, L; Kuttesch, J; Satterlee, W1
Greco, FA; Grindey, G; Hainsworth, JD; Hande, KR; Jackson, LE; Johnson, DH; Kuttesch, J; Satterlee, WG1
Alberts, DS; Hamilton, M; Holdsworth, MT; Ketcham, MA; McCloskey, TM; Peng, YM; Plezia, PM; Roe, DJ; Satterlee, WG; Taylor, CW1

Reviews

2 review(s) available for sulofenur and Neoplasms

ArticleYear
New anticancer agents.
    Cancer chemotherapy and biological response modifiers, 1991, Volume: 12

    Topics: Alkaloids; Animals; Antineoplastic Agents; Azacitidine; Biphenyl Compounds; Chrysenes; Deoxycytidine; Echinomycin; Epirubicin; Etanidazole; Flavonoids; Gemcitabine; Guanidines; Humans; Idarubicin; Menogaril; Mitoguazone; Neoplasms; Nitroimidazoles; Nogalamycin; Organoplatinum Compounds; Paclitaxel; Pentostatin; Polymers; Propylene Glycols; Ribavirin; Sulfonylurea Compounds; Trimetrexate; Vidarabine Phosphate

1991
Novel chemotherapeutic agents in early clinical development.
    Current opinion in oncology, 1990, Volume: 2, Issue:6

    Topics: Adenine; Alkaloids; Anthraquinones; Antineoplastic Agents; Biphenyl Compounds; Camptothecin; Humans; Imides; Irinotecan; Isoquinolines; Naphthalimides; Neoplasms; Organophosphonates; Paclitaxel; Pyrazoles; Quinazolines; Sulfonylurea Compounds; Terpenes; Trimetrexate

1990

Trials

4 trial(s) available for sulofenur and Neoplasms

ArticleYear
A phase I study of sulofenur in refractory pediatric malignant solid tumors.
    Investigational new drugs, 1995, Volume: 13, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Drugs, Investigational; Evaluation Studies as Topic; Humans; Neoplasms; Prognosis; Sulfonylurea Compounds

1995
Phase I trial of sulofenur (LY186641) given orally on a daily x 21 schedule.
    Anti-cancer drugs, 1994, Volume: 5, Issue:2

    Topics: Administration, Oral; Anemia; Antineoplastic Agents; Chromatography, High Pressure Liquid; Drug Administration Schedule; Female; Hemolysis; Humans; Male; Methemoglobinemia; Middle Aged; Neoplasms; Sulfonylurea Compounds

1994
Early clinical investigation of sulofenur with a daily schedule in advanced solid tumours.
    Investigational new drugs, 1997, Volume: 15, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Female; Humans; Male; Middle Aged; Neoplasms; Sulfonylurea Compounds

1997
Novel chemotherapeutic agents in early clinical development.
    Current opinion in oncology, 1990, Volume: 2, Issue:6

    Topics: Adenine; Alkaloids; Anthraquinones; Antineoplastic Agents; Biphenyl Compounds; Camptothecin; Humans; Imides; Irinotecan; Isoquinolines; Naphthalimides; Neoplasms; Organophosphonates; Paclitaxel; Pyrazoles; Quinazolines; Sulfonylurea Compounds; Terpenes; Trimetrexate

1990

Other Studies

4 other study(ies) available for sulofenur and Neoplasms

ArticleYear
[Antitumor activity of N-(5-indanylsulfonyl)-N'-(4-chlorophenyl)-urea, LY 186641 against various human cancers using subrenal capsule assay].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:1

    Topics: Antineoplastic Agents; Colorectal Neoplasms; Esophageal Neoplasms; Humans; Lymphoma; Neoplasms; Subrenal Capsule Assay; Sulfonylurea Compounds

1990
Kinetics of N-[(4-chlorophenyl)amino]carbonyl-2,3-dihydro-1H-indene-5-sulfonamide (LY186641) in humans.
    Cancer research, 1990, Jul-01, Volume: 50, Issue:13

    Topics: Administration, Oral; Half-Life; Humans; Methemoglobinemia; Neoplasms; Sulfonylurea Compounds; Time Factors

1990
Phase I clinical study of N-[(4-chlorophenyl)amino]carbonyl-2,3-dihydro-1H-indene-5-sulfonamide (LY186641).
    Cancer research, 1989, Sep-15, Volume: 49, Issue:18

    Topics: Antineoplastic Agents; Drug Evaluation; Female; Humans; Male; Methemoglobinemia; Middle Aged; Neoplasms; Sulfonylurea Compounds; Time Factors

1989
Clinical pharmacology of a novel diarylsulfonylurea anticancer agent.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1989, Volume: 7, Issue:11

    Topics: Adult; Aged; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Evaluation; Humans; Middle Aged; Neoplasms; Sulfonylurea Compounds; Tumor Stem Cell Assay

1989